{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:32:42Z","timestamp":1772155962011,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,28]]},"DOI":"10.1097\/qad.0b013e32835ab5b2","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T03:31:16Z","timestamp":1349148676000},"page":"369-379","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy and immunogenicity of influenza vaccine in HIV-infected children"],"prefix":"10.1097","volume":"27","author":[{"given":"Shabir A.","family":"Madhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Dittmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Locadiah","family":"Kuwanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marietjie","family":"Venter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haseena","family":"Cassim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teena","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaaf","family":"Liberty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florette","family":"Treurnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avy","family":"Violari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1067\/mpd.2000.105350","article-title":"Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1.","volume":"137","author":"Madhi","year":"2000","journal-title":"J Pediatr"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00006454-200204000-00007","article-title":"Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection.","volume":"21","author":"Madhi","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00006454-199504000-00022","article-title":"Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child.","volume":"14","author":"Evans","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1750-2659.2011.00241.x","article-title":"2009 versus 2010 comparison of influenza activity in southern hemisphere temperate countries.","volume":"5","author":"Van Kerkhove","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cyto.10068","article-title":"CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4 T-cell enumeration.","volume":"50","author":"Glencross","year":"2002","journal-title":"Cytometry"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200001273420401","article-title":"The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.","volume":"342","author":"Neuzil","year":"2000","journal-title":"N Engl J Med"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1073\/pnas.0903427106","article-title":"Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.","volume":"106","author":"Ndifon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/viro.2001.1121","article-title":"Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes.","volume":"289","author":"Medeiros","year":"2001","journal-title":"Virology"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2012.03.046","article-title":"Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHACCIHR Influenza Research Network (PCIRN) study.","volume":"30","author":"Langley","year":"2012","journal-title":"Vaccine"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(10)70117-1","article-title":"Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy.","volume":"10","author":"Cagigi","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/QAD.0b013e32833c3298","article-title":"The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children.","volume":"24","author":"Cagigi","year":"2010","journal-title":"AIDS"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jaci.2011.05.033","article-title":"Innate immune defects correlate with failure of antibody responses to H1N109 vaccine in HIV-infected patients.","volume":"128","author":"Pallikkuth","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R20-7-20210130","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virus.","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.aje.a113408","article-title":"Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness.","volume":"116","author":"Fox","year":"1982","journal-title":"Am J Epidemiol"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.","volume":"30","author":"Black","year":"2011","journal-title":"Pediat Infect Dis J"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/adc.76.3.215","article-title":"Response to influenza virus vaccination in vertical HIV infection.","volume":"76","author":"Lyall","year":"1997","journal-title":"Arch Dis Child"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00006454-199702000-00007","article-title":"Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus.","volume":"16","author":"Jackson","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-199603000-00004","article-title":"T cell activation and human immunodeficiency virus replication after influenza immunization of infected children.","volume":"15","author":"Ramilo","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00006454-199403000-00008","article-title":"Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children.","volume":"13","author":"Chadwick","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.vaccine.2011.01.091","article-title":"Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status.","volume":"29","author":"Kosalaraksa","year":"2011","journal-title":"Vaccine"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/aid.2010.0306","article-title":"Immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents.","volume":"27","author":"Machado","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/S0074-02762007005000055","article-title":"Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.","volume":"102","author":"Montoya","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciq004","article-title":"Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.","volume":"52","author":"Madhi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0b013e3181632cda","article-title":"Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.","volume":"48","author":"Vigano","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jmv.20559","article-title":"Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.","volume":"78","author":"Tanzi","year":"2006","journal-title":"J Med Virol"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1128\/CVI.05200-11","article-title":"Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted AH1N1 influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.","volume":"18","author":"Vigano","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1016\/j.vaccine.2011.08.101","article-title":"Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.","volume":"29","author":"Phongsamart","year":"2011","journal-title":"Vaccine"},{"key":"R37-7-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/aid.2009.0163","article-title":"T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.","volume":"26","author":"Weinberg","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R38-7-20210130","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2008.05.054","article-title":"Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.","volume":"26","author":"Levin","year":"2008","journal-title":"Vaccine"},{"key":"R39-7-20210130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QAI.0b013e3181e46308","article-title":"Antiinfluenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.","volume":"55","author":"Weinberg","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-7-20210130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biologicals.2011.12.001","article-title":"Safety and immunogenicity of a monovalent MF59(R)-adjuvanted AH1N1 vaccine in HIV-infected children and young adults.","volume":"40","author":"Palma","year":"2012","journal-title":"Biologicals"},{"key":"R41-7-20210130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children.","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"key":"R42-7-20210130","doi-asserted-by":"crossref","first-page":"1782S","DOI":"10.1093\/jn\/138.9.1782S","article-title":"Breast-feeding and its role in early development of the immune system in infants: consequences for health later in life.","volume":"138","author":"MRabet","year":"2008","journal-title":"J Nutr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32835ab5b2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:34:33Z","timestamp":1620956073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201301280-00007"}},"subtitle":["a randomized, double-blind, placebo controlled trial"],"short-title":[],"issued":{"date-parts":[[2013,1,28]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835ab5b2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717961965.793466311","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717961965.793465804","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,28]]}}}